Table 4. Multivariate-adjusted linear regression analysis showing relationships between different 25-OH-D forms and VZV gp-ELISA antibody levels.
| VZV-IgG | ||||
|---|---|---|---|---|
| Model * | Parameter estimates | Standard error | t-value | p value |
| Intercept | 524 | 200.9 | 2.61 | 0.01 |
| Total 25-OH-D > 27.8 | 14.1 | 6.3 | 2.24 | 0.03 |
| Cancer | −453.5 | 198.4 | −2.29 | 0.02 |
| Intercept | 2528.3 | 786.3 | 3.22 | <0.01 |
| Bioavailable 25-OH-D > 3.66 | 149 | 56.5 | 2.64 | 0.01 |
| Cancer | −639.2 | 197.8 | −3.23 | <0.01 |
*Adjusted for demographic data, comorbiditis, albumin, dialysis parameters, vintage, and use of active vitamin D.
Abbreviations: ELISA, enzyme-linked immuno-sorbent assay; VZV, varicella zoster virus.